Deemea logo

Deemea

Get insights from your imaging data

VS
FlowView Diagnostics logo

FlowView Diagnostics

AI-powered intelligent decision support for precise and automated flow cytometry data analysis.

Side-by-Side Comparison

Metric Deemea FlowView Diagnostics
Founded 2020 2020
Headquarters Paris, France Heerenveen, The Netherlands
Employees 20 4
Industry AI, Data Analytics, Health Care Health Care, Information Technology
Funding Stage Seed Series A
Total Funding $5.76M $1.05M
Funding Rounds 5 5
Business Model Not tracked yet SaaS, B2B, B2B2C
Revenue Model Not tracked yet Subscription, Usage Based, Service Fee
Services AI-powered imaging agent, clinical research platform for data management and analysis, real-time multicentric imaging data collection and sharing, regulatory compliance solutions Automated flow cytometry data analysis, AI algorithm for cell detection, Deterministic output for consistent results, Advanced data visualization
Target Customers Clinical research teams, hospitals, healthcare centers, medical institutions Laboratories, Hospitals, Research teams, Clinical Research Organizations (CROs), Healthcare professionals
Taxonomy AI-driven Medical Data Analysis, Imaging Data Processing, Digital Health Technology, Biopharmaceutical Clinical Studies, Medical Device Trials, Data Security And Privacy, Healthcare Facility Sustainability, Data-driven Research, Innovative Therapies, AI Assistant For Clinical Research, Medical Data Collaboration Platform AI-driven Solutions, Flow Cytometry, Intelligent Decision Support, Healthcare Analytics, Clinical Research Organizations, Automated Data Analysis, Disease-specific Cell Identification, Biomedical Innovation, Eclipse Algorithm, Cloud-based Software, Data Visualization, Standardized Protocols, Medical Parameters Analysis, Research Collaboration
Website deemea.com flowview.eu
Deemea logo

About Deemea

Deemea, a digital health company founded in 2020, focuses on AI-driven structuring and analysis of medical data under the slogan "Get insights from your imaging data." The company's expertise lies in processing imaging data, leading to the development of a collaborative platform for medical data ana...

FlowView Diagnostics logo

About FlowView Diagnostics

FlowView Diagnostics is an innovative player in the intersection of Health Care and Information Technology, established in 2020 and headquartered in The Netherlands. The company specializes in AI-powered flow cytometry solutions, offering the Asudes platform, which utilizes the patented Eclipse algo...

Frequently Asked Questions

Deemea — Get insights from your imaging data. FlowView Diagnostics — AI-powered intelligent decision support for precise and automated flow cytometry data analysis.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Deemea has raised $5.76M while FlowView Diagnostics has raised $1.05M.
Deemea and FlowView Diagnostics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Track both companies in real time

Signal Tracker monitors Deemea, FlowView Diagnostics, and millions of companies for 40+ signal types.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy